Patent · US Active

Stabilized assembled nanostructures for delivery of encapsulated agents

US9962339B2 · kind B2 · utility

6Cited by
3References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 7, 2016
Grant dateMay 8, 2018
Priority date
Expiry dateOct 7, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A non-covalently assembled hydrogel or organo-gel composition with serum stability is described. Low molecular weight (<2,500 Da), generally regarded as safe (GRAS), materials assemble in the presence of a stabilizing agent at an appropriate molar percentage, forming hydrogel or organo-gel with nanostructures that resist disassembly or destabilization in serum for an extended period of time. The composition is used to deliver one or more therapeutic, prophylactic, or diagnostic agents, allowing for controlled release in response to biological stimuli such as enzymes and a greatly improved dosing efficacy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.